Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)

https://doi.org/10.1016/j.bmcl.2008.12.114Get rights and content

Abstract

The synthesis and SAR of a series of arylsulfonylpiperazine inhibitors of 11β-HSD1 are described. Optimization rapidly led to potent, selective, and orally bioavailable inhibitors demonstrating efficacy in a cynomolgus monkey ex vivo enzyme inhibition model.

Graphical abstract

The synthesis and SAR of a series of arylsulfonylpiperazine inhibitors of 11β-HSD1 are described. Optimization rapidly led to potent, selective, and orally bioavailable inhibitors demonstrating efficacy in a cynomolgus monkey ex vivo enzyme inhibition model.

  1. Download : Download full-size image

References and notes (21)

  • S. Olson et al.

    Bioorg. Med. Chem. Lett.

    (2005)
  • X. Gu et al.

    Bioorg. Med. Chem. Lett.

    (2005)
  • J. Xiang et al.

    Bioorg. Med. Chem. Lett.

    (2005)
  • V.S.C. Yeh et al.

    Bioorg. Med. Chem. Lett.

    (2006)
    V.S.C. Yeh et al.

    Bioorg. Med. Chem. Lett.

    (2006)
    V.S.C. Yeh et al.

    Bioorg. Med. Chem. Lett.

    (2006)
    D.J. St Jean et al.

    J. Med. Chem.

    (2007)
  • L.D. Julian et al.

    J. Med. Chem.

    (2008)
  • D. Sun et al.

    Bioorg. Med. Chem. Lett.

    (2008)
  • K.G.S. Prakash et al.

    Chem. Rev.

    (1997)
  • N. Draper et al.

    J. Endocrinol.

    (2005)
  • R. Thieringer et al.

    Expert Rev. Cardiovasc. Ther.

    (2005)
There are more references available in the full text version of this article.

Cited by (23)

  • Application of carbamyl in structural optimization

    2020, Bioorganic Chemistry
    Citation Excerpt :

    Water solubility was elevated to more than 48 μg/mL from 0.5 μg/mL of compound 22 in pH 5.0 solution as expected, the oral bioavailability was improved to 41% in rats. Best of all, it showed good efficacy in cynomolgus monkey ex vivo pharmacodynamic model measured by lowering 11β-HSD1 adipose activity [88]. The IC50 values towards 11β-HSD1 enzyme and 11β-HSD1 adipocyte of carbamate-bearing compound 24 (Fig. 5) were 5 nM and 53 nM respectively.

  • Human hydroxysteroid dehydrogenases and pre-receptor regulation: Insights into inhibitor design and evaluation

    2011, Journal of Steroid Biochemistry and Molecular Biology
    Citation Excerpt :

    For HSDs that belong to the SDR superfamily, non-steroidal based ligands have been based on a number of different pharmacophores. For type 1 11β-HSD, inhibitor series include diverse scaffolds: triazoles (Merck-544) and azabicyclic sulphonamides developed by both Merck and Eli Lilly [76,77]; pentanedioic acid diamides developed by Merck-Serono [78]; pyridinyl arylsulfonamides developed by Pfizer (PF-915275) [79]; (phenylsulfonamido-methyl)-nicotine and (phenylsulfonamido-methyl)-thiazole derivatives [80]; arylsulfonylpiperazines, piperdyl- and cyclo-benzamides developed by Amgen (Amgen 2922) [81–83]; thiazolones developed by Biovitrum (BVT-2733) [84]; 1,5-substituted-1H-tetrazoles developed by the group at Edinburgh [85]; and adamantyl ethanones developed by Ipsen/Sterix [86]. Many of these have nM affinity for the target.

View all citing articles on Scopus

Present address: ChemoCentryx, Inc., Mountain View, CA 94043, USA.

Present address: Lundbeck Research USA, Inc., 215 College Road, Paramus, NJ 07652, USA.

View full text